Dana Farber Cancer Center Institute

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

Breast Cancer, Metastatic Breast Cancer, Stage IV Breast Cancer, Triple Negative Breast Cancer

Studies at this site

• Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer — Completed